Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-β treatment

V. Martinelli, M. Gironi, M. Rodegher, G. Martine, G. Comi

Research output: Contribution to journalArticlepeer-review

Abstract

We have analyzed the titer of antithyroid autoantibodies (Abs) and thyroid function in 17 multiple sclerosis (MS) patients undergoing interferon-β (IFN-β) treatment and in 40 MS control patients. Basal evaluation revealed normal thyroid function in all patients. Abs were detected in 5 IFN-β-treated patients (29%) and in 4 MS control patients (10%). Our results indicate that IFN-β treatment may lead to thyroid autoimmunity. We therefore recommend periodic evaluations of antithyroid Abs and thyroid functionality in IFN-β-treated MS patients.

Original languageEnglish
Pages (from-to)65-67
Number of pages3
JournalItalian Journal of Neurological Sciences
Volume19
Issue number2
Publication statusPublished - 1998

Keywords

  • Autoimmunity
  • Interferon beta
  • Multiple sclerosis
  • Thyroiditis

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-β treatment'. Together they form a unique fingerprint.

Cite this